HSHHSH Health Technology Supplier Hub
Home › Suppliers › Hamamatsu Photonics › Risk

Hamamatsu Photonics: risk summary

Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.

Financial

Latest full-year results from official filings.

Listed (6965.T).

Latest full-year results not yet captured by HSH.

Researched 8 Nov 2026

Adverse media

Credible news about incidents, disputes, legal action or restructuring in the last 24 months.

No adverse media involving Hamamatsu Photonics found in HSH's search of the last 24 months.

Researched 10 Nov 2026

Cyber & information governance

Data breaches, cyber incidents, regulator action and assurance status.

No data breaches, cyber incidents or regulator action involving Hamamatsu Photonics found in HSH's search of the last 24 months. NHS DSPT status not yet checked.

Researched 10 Nov 2026

Regulatory & clinical safety

Recalls, safety notices, regulator action and clinical safety concerns.

No product recalls, safety notices or warning letters involving Hamamatsu Photonics' NanoZoomer digital pathology scanners found in HSH's search of the last 24 months.

Researched 10 Nov 2026

Contract performance

Contract delivery, go-lives, terminations and disputes.

No notable contract disputes, terminations or troubled implementations involving Hamamatsu Photonics found in HSH's search of the last 24 months.

Researched 10 Nov 2026